199550.Kq
The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
Business. The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the healthcare equipment industry, specializing in the design, development, and sale of advanced medical equipment and technology.
The company's capital structure is characterized by a debt-to-equity ratio of 0.45, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, with a current ratio of 2.31, suggesting it can cover its short-term obligations but with limited excess capacity. The company holds cash and equivalents of KRW 5,515,372,950, but this is offset by long-term debt of KRW 10,044,157,310, resulting in a net cash position that is negative after subtracting total debt.
Profitability metrics are concerning, with a return on equity of -48.44% and a return on assets of -29.39%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating loss of KRW 11,873,719,200 and net loss of KRW 10,743,981,000 further underscore the company's financial distress. Gross profit of KRW 9,867,677,660 is insufficient to cover operating expenses, highlighting the need for cost optimization or revenue growth.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdowns in the input data limits the ability to assess the company's risk profile in detail.
The company's growth trajectory is negative, with a net loss and declining operating cash flow. The operating cash flow of -KRW 6,392,070,450 and free cash flow of -KRW 9,688,732,390 indicate that the company is not generating sufficient cash from operations to sustain its activities. The capital expenditure of -KRW 714,873,390 suggests ongoing investment, but without corresponding revenue growth, this may exacerbate financial strain.
Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is assessed as low. The company's negative net cash position and operating losses increase the risk of financial distress. The risk assessment highlights the need for improved cash flow generation and cost management to mitigate these risks.
Recent events, as disclosed in the latest financial filings, include a significant operating loss and net loss. The company has not provided detailed explanations for these losses, but the negative cash flows and high debt levels suggest operational challenges. No recent transcripts or filings provide additional context on strategic initiatives or cost-cutting measures.
- The company is experiencing significant financial distress, with a net loss and negative cash flows.
- The debt-to-equity ratio is relatively low, but the company's liquidity is constrained by negative net cash after debt.
- Profitability metrics are severely negative, indicating poor returns on equity and assets.
- The company's revenue and operations are not diversified, increasing exposure to regional and sector-specific risks.
- The company's growth trajectory is negative, with no signs of improvement in operating performance.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 199550.KQ Market data — financials · 2026-05-26
Ownership & reference
Leadership
- Chang Jin LeePresident, Chief Executive Officer